Reuters logo
BRIEF-New CIMZIA findings presented at European Academy Of Dermatology And Venereology (EADV) Congress
September 14, 2017 / 12:21 PM / 10 days ago

BRIEF-New CIMZIA findings presented at European Academy Of Dermatology And Venereology (EADV) Congress

Sept 14 (Reuters) - Dermira Inc

* New CIMZIA (certolizumab pegol) findings presented at European Academy of Dermatology and Venereology (EADV) Congress

* Dermira Inc - ‍treatment with CIMZIA was associated with significant and clinically meaningful improvements in quality of life and work productivity​

* Dermira Inc - ‍no new safety signals were observed in psoriasis trials and safety profile remains consistent with cimzia’s other indications​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below